A carregar...
Treatment of aggressive lymphomas with anti-CD19 CAR T cells
Adoptive immunotherapy using T cells genetically engineered to express a chimeric antigen receptor that targets CD19, a B-cell differentiation antigen, has demonstrated impressive efficacy in a range of B-lymphoid malignancies. The latest results demonstrate the potential of this approach in patient...
Na minha lista:
| Publicado no: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327311/ https://ncbi.nlm.nih.gov/pubmed/25384948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2014.190 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|